BioAtla, Inc. (BCAB) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-12

Key Insights

The reporting person, Christian Vasquez, who is the Chief Financial Officer of BioAtla, Inc. (BCAB), acquired 240,000 shares of the company's common stock through a time-based restricted stock unit (RSU) award.
The RSU award will vest over time, with 25% vesting on March 10, 2027, and the remaining 75% vesting in quarterly installments thereafter, subject to Vasquez's continued service with the company.
This insider acquisition suggests that the CFO is confident in the company's future prospects and aligns his interests with those of shareholders.

Want the newest filings?

This analysis covers the filing from 2026-03-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-12

The reporting person, Jay M. Short, PhD, the Chief Executive Officer and a Director of BioAtla, Inc. (BCAB), acquired 430,000 shares of BCAB common stock through a time-based restricted stock unit (RSU) award.
Short also holds significant indirect beneficial ownership in BCAB through his spouse and various trusts, totaling over 1.6 million shares.
This transaction suggests that the CEO remains highly committed to the company and confident in its future prospects.

Filed: 2026-03-12

Eric Sievers, the Chief Medical Officer of BioAtla, Inc., has been granted 240,000 shares of common stock in the form of restricted stock units (RSUs), which will vest over time as he continues his service with the company.
Sievers' direct beneficial ownership of BioAtla's common stock has increased to 598,705 shares following this grant, indicating his continued commitment and alignment with the company's long-term success.
The RSU grant is a common form of equity-based compensation, aligning the interests of key executives with those of shareholders and incentivizing long-term retention and performance.

Other reports for BioAtla, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.